| No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
| 1 | general cells |
IFO50077 |
IT-45R91 |
rat |
thymus |
thymic fibroblast, (Wistar rat) |
|
| 2 | general cells |
JCRB0025 |
BRL-3A |
rat |
liver |
MSA (somatomedin-like) protein producing, (Buffalo rat) |
|
| 3 | general cells |
JCRB0072 |
MiTen |
human |
skin |
Human cell line from Lesch-Nyhan syndrome. |
|
| 4 | general cells |
JCRB0073 |
J-111 |
human |
peripheral blood |
The cell line deposited as a human acute monocytic leukemia but many data show this cell line is a subline of the HeLa. |
|
| 5 | general cells |
JCRB0104.1 |
KU812E |
human |
peripheral blood |
leukemia, chronic myeloid |
|
| 6 | general cells |
JCRB0104.2 |
KU812F |
human |
peripheral blood |
leukemia, chronic myeloid |
|
| 7 | general cells |
JCRB0144.1B |
LYM-1.P3B |
rat |
|
Serum free FAR-2.F60 rat cell culture from lymph node near colon cancer. |
|
| 8 | general cells |
JCRB0206 |
PCC4 AG |
mouse |
cybrid |
teratocarcinoma, 8-azaguanine-resistant, (129/Sv mouse) |
|
| 9 | general cells |
JCRB0224 |
WiDr |
human |
colon |
adenocarcinoma |
|
| 10 | general cells |
JCRB0239 |
TCO-1 |
human |
thyroid gland |
non differentiated cancer |
|
| 11 | general cells |
JCRB0245 |
RMT-1 M2 |
rat |
mammary gland |
Rat mammary carcinoma cell line from rat mammary gland induced by single shot DMBA(20mg) administrated by oral. |
|
| 12 | general cells |
JCRB0251 |
SCH |
human |
stomach |
choriocarcinoma arising at stomach from male patient |
|
| 13 | general cells |
JCRB0627 |
KYM-1 |
human |
neck |
Human rhabdomyosarcoma cell line derived from neck tumor. |
|
| 14 | general cells |
JCRB0711 |
T24 |
human |
bladder |
urinary bladder carcinoma |
|
| 15 | general cells |
JCRB0737 |
Ad12-3Y1-Z19 |
rat |
embryo/fetal whole body |
3Y1 derivative, Ad12-transformed, (Fischer rat) |
|
| 16 | general cells |
JCRB1075.1 |
IM95m |
human |
stomach |
Human gastric cancer cell line. |
|
| 17 | general cells |
JCRB1080.1 |
HARA-B |
human |
mouse bone metastasis |
HARA cell (human lung squamouse cell carcinoma) established from bone metastasis in nude mouse. |
|
| 18 | general cells |
JCRB1133 |
UE6E7T-2 |
human |
bone marrow |
Human bone marrow-derived mesenchymal stem cells. |
|
| 19 | general cells |
JCRB1401 |
Kasumi-7 |
human |
blood |
B cell leukemia |
|
| 20 | general cells |
JCRB1405 |
Minami-2 |
human |
lymphonode |
B cell lymphoma (Burkitt type) |
|
| 21 | general cells |
JCRB1442 |
ASF-4-4L2 |
human |
skin |
Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3 and the ASF-4-4 lines were established from skins of the same donor at different ages. |
|
| 22 | general cells |
JCRB1601 |
EMTOKA |
human |
Uterine body |
Human cell line derived from uterine carcinosarcoma. |
|
| 23 | general cells |
JCRB1878 |
HSC-43 |
human |
stomach |
Human signet ring cell gastric carcinoma cell line. Established from primary gastric tumor. |
|
| 24 | general cells |
JCRB9095 |
HEPM |
human |
embryo |
embryonic palatal mesenchyme, limited life span |
|
| 25 | general cells |
JCRB9117 |
BCL1 Clone CW13.20 |
mouse |
peripheral blood |
Mouse B cell line, where the differentiation is stimulated by B cell differentiation factors. |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.